|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
27
|
|
pubmed:dateCreated |
2009-10-2
|
|
pubmed:abstractText |
Vinflunine (VFL) is a new microtubule inhibitor that has activity against transitional cell carcinoma of urothelial tract (TCCU). We conducted a randomized phase III study of VFL and best supportive care (BSC) versus BSC alone in the treatment of patients with advanced TCCU who had experienced progression after a first-line platinum-containing regimen.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:BellmuntJoaquimJ,
pubmed-author:CarlesJoanJ,
pubmed-author:CatyArmelleA,
pubmed-author:CulineStéphaneS,
pubmed-author:DaugaardGedskeG,
pubmed-author:DelgadoFrançois-MichelFM,
pubmed-author:DemkovTomaszT,
pubmed-author:HurteloupPatrickP,
pubmed-author:Jagiello-GruszfeldAgnieszkaA,
pubmed-author:KaryakinOlegO,
pubmed-author:KomyakovBorisB,
pubmed-author:MorsliNassimN,
pubmed-author:SalhiYacineY,
pubmed-author:SengelovLisaL,
pubmed-author:ThéodoreChristineC,
pubmed-author:WinquistEricE,
pubmed-author:von der MaaseHansH
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4454-61
|
|
pubmed:dateRevised |
2010-5-3
|
|
pubmed:meshHeading |
pubmed-meshheading:19687335-Aged,
pubmed-meshheading:19687335-Antineoplastic Agents,
pubmed-meshheading:19687335-Carcinoma, Transitional Cell,
pubmed-meshheading:19687335-Disease Progression,
pubmed-meshheading:19687335-Humans,
pubmed-meshheading:19687335-Middle Aged,
pubmed-meshheading:19687335-Palliative Care,
pubmed-meshheading:19687335-Platinum Compounds,
pubmed-meshheading:19687335-Survival Analysis,
pubmed-meshheading:19687335-Urologic Neoplasms,
pubmed-meshheading:19687335-Urothelium,
pubmed-meshheading:19687335-Vinblastine
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract.
|
|
pubmed:affiliation |
Department of Medical Oncology, University Hospital Del Mar, Passeig Marítim 25-29, E-08003 Barcelona, Spain. jbellmunt@imas.imim.es
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|
